Department of Pharmacology & Toxicology

Marjolein Drent
Other

Interstitial lung diseases


m.drent@hetnet.nl
+31 646307640

Prof. Marjolein Drent (1955) studied physical therapy at the Arnhem Academy of Physical Therapy, the Netherlands (NL). She finished her medical study in 1988 at the Catholic University of Nijmegen, NL. In 1993 she completed her thesis entitled: ‘Diagnostic value of bronchoalveolar lavage in interstitial lung diseases.’ After she finished her training as a pulmonologist in 1994 at the St. Antonius Hospital (Nieuwegein, NL) she was appointed from 1994 to 2012 at the Department of Respiratory Medicine of the Maastricht University Medical Centre (MUMC), NL. Since 2005 she is appointed as professor of interstitial lung diseases (ILD) at the Department of Pharmacology and Toxicology of the Faculty of Health and Life Sciences of the University of Maastricht, NL. Her oration was entitled: ‘Breathtaking inspirations…’ (www.ildcare.nl/en/index.php/publications/). Currently, she is - as a pulmonologist - a member of the ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands. She is the current President of the WASOG (World Association of Sarcoidosis and other Granulomatous diseases; www.wasog.org). She is Chief Editor of Current Opinion in Pulmonary Medicine. She is associate editor of Sarcoidosis Vasculitis and Diffuse Lung Diseases. She (co-) authored over 300 papers and book chapters.

She is number 5 on the list World’s Top specialist in Sarcoidosis research the last 10 years. Furthermore, she is concerned with several educational assignments, organisation of postgraduate courses and clinical trials. In 2011 she organized the second combined 10th WASOG Meeting and the 12th International Conference on BAL in Maastricht, NL. Currently, she is involved in clinical, biochemical and genetic research into inflammation focusing on interstitial lung diseases, including occupational and environmental related disorders, pharmacogenomics, translational medicine and e-health. Prevention and Personalized Medicine (www.ildcare.nl/en/index.php/proefschriften/) became one of the main themes in her research. Since 2015 she is chair of the Foundation for Sarcoidosis Research (FSR: www.stopsarcoidosis.org) Scientific Advisory Board (SAB).

She is the founder and chair of the ild care (interstitial lung diseases including sarcoidosis
and lung diseases related to occupation and environment management and research) foundation (please visit: www.ildcare.nl). The ild care research team participated in several international trials aimed to improve the therapeutic approach of patients suffering from sarcoidosis or idiopathic pulmonary fibrosis (IPF). She was involved in various clinical trials as a principal investigator. She is a honorary member of the SBN (Dutch Sarcoidosis Society) and founder and a member of the advisory board of the Dutch Pulmonary Fibrosis Society. In 2007 she received the Novartis Pulmonology award. This was awarded by a national jury because of her dedication to achieve improvement of the quality of life of patients. She was selected as the leading physician of 2011 as well as 2012 by her colleague Dutch pulmonary physicians. In 2012 she was nominated for the ‘World Sarcoidosis Person of the Year Award’ for her tireless research work in defining the psychological burden faced by patients and their families. Dublin, Ireland. 15-11-12.This award is selected by patients of the Irish Sarcoidosis Support Network (ISarc). She is ambassador for Compassion for Care (www.compassionforcare.com/en/) and the Stichting Rookpreventie Jeugd (www.stichtingrookpreventiejeugd.nl/).

Associated Projects

Antioxidant networks

Antioxidant networks in health and disease More »